US Broker Ratings

Scholar Rock Holding Corporation (SRRK) Stock Analysis: A Biotech Innovator with a 13% Potential Upside

Scholar Rock Holding Corporation (NASDAQ: SRRK), a Cambridge-based biopharmaceutical company, is making headlines with its innovative approach in the biotechnology sector. Focusing on the discovery and development of novel therapies,..

Tandem Diabetes Care, Inc. (TNDM) Stock Analysis: Navigating a Path with a 20% Upside Potential

Tandem Diabetes Care, Inc. (TNDM) stands as a significant player in the healthcare sector, specifically within the medical devices industry. Headquartered in San Diego, California, Tandem Diabetes focuses on developing..

Sotera Health Company (SHC) Stock Analysis: Strong Buy Ratings and 7.68% Potential Upside

Sotera Health Company (NASDAQ: SHC) is drawing attention from investors with a strong buy consensus and a promising potential upside. As a leading player in the healthcare sector, particularly in..

CONMED Corporation (CNMD) Stock Analysis: A Look at Healthcare’s Undervalued Player with 11% Upside Potential

CONMED Corporation (NASDAQ: CNMD), a key player in the medical devices sector, stands as an intriguing prospect for investors seeking exposure in the healthcare industry. With a market capitalization of..

Envista Holdings Corporation (NVST) Stock Analysis: A Healthcare Player with a Mixed Growth Outlook

Envista Holdings Corporation (NYSE: NVST) is an intriguing entity in the healthcare sector, focusing on the medical instruments and supplies industry. As of the latest data, Envista boasts a market..

Guardian Pharmacy Services, Inc (GRDN) Stock Analysis: Evaluating a 10.28% Potential Upside for Investors

Guardian Pharmacy Services, Inc. (GRDN), a pivotal player in the healthcare sector, specifically within the medical care facilities industry, is capturing the attention of investors with its promising growth metrics..

Harmony Biosciences Holdings (HRMY) Stock Analysis: Strong Growth, Attractive Valuation, and Promising Upside

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY), a prominent player in the biotechnology sector, is catching the eye of investors with its robust growth trajectory and promising pipeline of neurological therapies...

GeneDx Holdings Corp. (WGS) Stock Analysis: Evaluating the 43.32% Potential Upside in the Genomic Sector

GeneDx Holdings Corp. (NASDAQ: WGS) stands at the intersection of cutting-edge genomics and diagnostics, carving a niche in the healthcare industry with its pioneering genetic testing services. As investors eye..

Select Medical Holdings Corp (SEM): Investor Outlook with 21.45% Potential Upside

Select Medical Holdings Corp (NYSE: SEM) is making waves in the healthcare sector, particularly in the medical care facilities industry. Based in the United States, this company is a prominent..

Enovis Corporation (ENOV) Stock Analysis: Exploring the 68.66% Potential Upside for This Medical Device Innovator

Enovis Corporation (NYSE: ENOV) is making waves in the healthcare sector, particularly in the medical devices industry. With a market capitalization of $1.54 billion, this Wilmington, Delaware-based company is carving..

Progyny, Inc. (PGNY) Stock Analysis: Analyst Consensus and Growth Potential in the Fertility Benefits Sector

Progyny, Inc. (NASDAQ: PGNY), a prominent player in the healthcare sector, is gaining substantial attention from investors, thanks largely to its innovative approach to fertility and family-building benefits. As a..

Twist Bioscience Corporation (TWST): Investor Outlook Reveals 16.9% Revenue Growth and Bullish Analyst Ratings

Twist Bioscience Corporation (NASDAQ: TWST), a pioneering entity in the healthcare sector focused on diagnostics and research, has captured investor attention with its robust revenue growth and favorable analyst ratings...

BGM Group Ltd. (BGM): Navigating the Challenges in the Healthcare Sector

BGM Group Ltd. (BGM), a prominent player in the healthcare sector, operates within the specialized and generic drug manufacturing industry in China. Despite its significant market capitalization of $770.39 million,..

Vericel Corporation (VCEL) Stock Analysis: Unveiling a 50% Upside in the Biotech Sector

Vericel Corporation (NASDAQ: VCEL), a prominent player in the biotechnology sector, has recently caught the attention of investors due to its promising potential upside of 50.31%, according to analyst ratings..

NewAmsterdam Pharma (NAMS) Stock Analysis: A Biotech with 46% Upside Potential

NewAmsterdam Pharma Company N.V. (NASDAQ: NAMS) is capturing investor attention with its promising pipeline and substantial upside potential. As a late-stage biopharmaceutical company based in Naarden, the Netherlands, its focus..

Concentra Group Holdings Parent (CON): Investor Outlook on 38% Potential Upside

Concentra Group Holdings Parent, Inc. (CON) is gaining significant attention from investors, particularly those interested in the healthcare sector. As a provider of essential occupational health services across the United..

LifeStance Health Group, Inc. (LFST) Stock Analysis: 19% Upside Potential and Strong Buy Ratings

LifeStance Health Group, Inc. (NASDAQ: LFST), a prominent player in the healthcare sector, is capturing investor attention with its robust growth prospects and a notable potential upside. Specializing in outpatient..

Apellis Pharmaceuticals (APLS) Stock Analysis: A 50% Upside Potential in the Biotech Sector

Apellis Pharmaceuticals, Inc. (NASDAQ: APLS), a key player in the biotechnology sector, presents a compelling opportunity for investors with its promising pipeline and strategic collaborations. With a market capitalization of..

Perrigo Company plc (PRGO) Stock Analysis: Exploring a 40.56% Upside Potential for Investors

Perrigo Company plc (NYSE: PRGO), a stalwart in the healthcare sector, primarily operates within the drug manufacturing space with a focus on both specialty and generic products. Headquartered in Dublin,..

CG Oncology, Inc. (CGON) Stock Analysis: Unveiling a Potential 42% Upside in the Biotech Space

CG Oncology, Inc. (NASDAQ: CGON) is drawing significant attention from the investment community, not only due to its promising pipeline in the oncology sector but also because of its robust..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds